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Previously, it has been shown that background color conditions regulate the 
overall activity of the frog intermediate lobe by varying the proportions of the 
two subtypes of melanotropes existing in the gland, the highly active or 
secretory melanotropes and hormone-storage melanotropes, depending on 
melanocyte-stimulating hormone (α-MSH) requirements. However, the factors 
and mechanisms underlying these background-induced changes are still 
unknown. In the present study, we investigated whether hypothalamic factors 
known to regulate melanotrope cell function can induce changes in vitro similar 
to those caused by background adaptation in vivo. We found that the inhibitors 
apomorphine (a dopamine receptor agonist) and NPY decreased the number of 
active melanotropes and increased simultaneously that of storage 
melanotropes. On the other hand, the stimulator TRH increased the number of 
active cells and concomitantly reduced that of storage cells. Inasmuch as none 
of these treatments modified the apoptotic and proliferation rates in 
melanotrope cells, it appears that these hypothalamic factors caused actual 
interconversions of cells from a subpopulation to its counterpart. When taken 
together, these findings suggest that the hypothalamus would control 
melanotrope activity not only through short-term regulation of hormone 
synthesis and release, but also through a long-term regulation of the secretory 
phenotype of these cells whereby the activity of the intermediate lobe would be 
adjusted to fulfill the hormonal requirements imposed by background 
conditions.
Keywords: dopamine, melanotrope cell heterogeneity, NPY, secretory cycle, 
TRH.
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IN AMPHIBIANS, melanotrope cells of the intermediate lobe regulate a 
unique physiological process, the adaptation of skin pigmentation to 
background color conditions (1, 2). Thus, high plasma levels of the hormone 
produced by these cells, melanocyte-stimulating hormone (α-MSH), induces the 
dispersion of the pigment melanin in dermal melanophores causing darkening 
of the skin, whereas low level of α-MSH prompts aggregation of the pigment 
and, consequently, skin paling. In a series of studies carried out in our 
laboratory, we have demonstrated that in the frog Rana ridibunda the overall 
activity of the intermediate lobe is adjusted by the proportions of two 
melanotrope cell subtypes, named as high- (HD) and low-density (LD) 
melanotropes based in their sedimentation characteristics in Percoll density 
gradients (3-5). According to their morphofunctional characteristics, HD 
melanotropes can be defined as a hormone-storage cell subset, because they 
show high α-MSH intracellular content but low mRNA levels of the prohormone 
precursor proopiomelanocortin (POMC) as well as a low basal α-MSH secretory 
rate, whereas LD cells show opposite features, indicative of high biosynthetic 
and secretory activities, and can therefore be considered as secretory 
melanotropes. Furthermore, we have also shown that the secretory LD 
melanotrope subpopulation largely predominated over the hormone-storage HD 
subset in the intermediate lobe of black background-adapted frogs (6, 7) which 
require high plasma α-MSH levels to sustain skin darkening. In contrast, the 
proportions of the two cell subsets were balanced under conditions of lower 
hormonal demand, in white-adapted animals (6, 7). These changes in the 
proportions of secretory and storage melanotropes between the two distinct 
physiological conditions occurred in the absence of variations in the apoptotic 
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and proliferation rates of cells, which suggested that melanotropes from a 
subpopulation convert into their counterparts according to the color of the 
background (6, 7). In other words, that melanotropes can pass from a relatively 
inactive (i.e. HD cells) to an active cellular state (i.e. LD cells) in response to the 
physiological demands of α-MSH.
These results have led our group to propose that, as suggested for other 
endocrine cell types (8-14), the morphologically and functionally distinct 
subtypes or subpopulations of cells that comprise the total population of 
melanotropes are in fact the reflection of different phases that occur at a given 
point in time within a dynamic and complex secretory cycle, which would 
operate, albeit with diverse specific features, in any endocrine cell type. 
Nevertheless, the mechanisms that govern the acquisition of a particular state 
of cellular activity and therefore determine the conversion of cells from a 
subpopulation to the other remain to be elucidated. Inasmuch as in amphibians 
melanotrope cell activity is directly regulated by the hypothalamus (for review 
see 15), it is conceivable that hypothalamic neurohormones modulate the 
timing of this secretory cycle. Accordingly, the aim of the present study has 
been to ascertain whether known hypothalamic regulators of the frog 
intermediate lobe, such as the inhibitors dopamine (15-18) and NPY (15, 17-
23), and the stimulator TRH (15, 24-26), are able to induce the interconversion 
of cells from the two frog melanotrope subpopulations, as well as to analyze the 
relationship between the control of the dynamics of the melanotrope secretory 




Leibovitz culture medium, Collagenase type V, trypsin type I, bovine 
serum albumin (BSA), Triton X-100, 5-bromo-2'-deoxyuridine (BrdU), anti-BrdU 
monoclonal antibody, biotinylated goat anti-mouse IgG, diaminobenzidine 
tetrahydrochloride (DAB), and the antibiotic-antimycotic solution were 
purchased from Sigma Chemical Co. (St Louis, MO). Percoll solution was 
obtained from Pharmacia LKB (Uppsala, Sweden). Fetal bovine serum (FBS) 
was from Gibco BRL (Grand Island, NY). Plastic 6-well culture plates and 35-
mm plates were from Costar (Cambridge, MA). Avidin-biotin peroxidase 
complex was from Vector Laboratories (Burlingame, CA). Apomorphine and 
thyrotropin-releasing hormone (TRH) were from ICN Inc. (Costa Mesa, CA). 
Frog NPY (melanostatin) was synthesized by the solid-phase method (27).
Animals
Adult male frogs (Rana ridibunda) of about 40 g body weight were 
purchased from a commercial supplier (J.R. Garcia Jardor, Mosqueiro, 
Ourense, Spain). Animals were maintained under running water at constant 
temperature (8ºC) with a 12-h light:12-h dark cycle, for at least 1 week before 
experiments started. Skin color adaptation was performed by keeping the 
animals under constant illumination on either a black or a white background for 
3 weeks. The frogs were killed by decapitation between 8:00 and 9:00 a.m. and 
the neurointermediate lobes were dissected under a microscope. Animal 
manipulations were performed according to the recommendations of the local 
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ethical committees at our institutions and under the supervision of authorized 
investigators.
Isolation of melanotrope cells
Isolated melanotrope cells were obtained using a dispersion protocol as 
previously described (3). Briefly, for each experiment, 30-40 neurointermediate 
lobes from either black or white background-adapted animals were collected 
and enzymatically dissociated by incubation at 26ºC for 45 min in culture 
medium [Leibovitz medium diluted 2:3 (to adjust to Rana ridibunda osmolality) 
and supplemented with 1 mM glucose, 0.4 mM CaCl2, and 1% antibiotic-
antimycotic solution] containing 0.2% collagenase type V and 0.2% trypsin type 
I. Then, cells were incubated sequentially in the same medium supplemented 
with 2 mM and 1 mM EDTA for 5 min each. Afterwards, cells were mechanically 
dispersed using a siliconized Pasteur pipette until a homogeneous cellular 
suspension was obtained. The total number of cells and the cellular viability 
were determined by the Trypan blue exclusion test in a Neubauer chamber.
Cell culture
Dispersed melanotrope cells from black- or white-adapted animals were 
plated at a density of 300,000 cells/200 µl culture medium into 6-well culture 
plates and allowed to attach to the plate for 60 min. Subsequently, cell cultures 
received 1,800 µl/well culture medium supplemented with 10% FBS and 0.1% 
gentamicin sulfate, containing the corresponding test substances. Specifically, 
cultures from black-adapted frogs were incubated with 10-4 M apomorphine or 
10-7 M NPY, and those from white-adapted frogs with 10-5 M TRH, at 26ºC for 
72 h. As controls, cells from either black- or white-adapted frogs were cultured 
7
in medium alone under the same incubation conditions than those treated with 
the corresponding factors. In all experimental groups, treatment was renewed 
daily.
For the determination of the apoptotic and proliferation rates of 
melanotropes in culture, 40,000 cell-aliquots from the initial cell suspension, 
obtained after the dispersion of intermediate lobes from either black- or white-
adapted frogs, were plated in 35-mm plastic dishes. These cultures received 
the same experimental treatments as those described above.
Separation of melanotrope subpopulations
After the 72-h culture period in the presence or absence of the 
corresponding test substance, cells were detached from the plates by 
sequential incubation in Leibovitz medium containing 2 mM EDTA for 20 min, 
and 1 mM EDTA plus 0.05% trypsin for 15 min. Thereafter, the medium 
containing the cells was centrifuged at 750 X g for 5 min, and the pellets were 
resuspended in 1 ml Leibovitz medium. Cells recovered from the wells that had 
received the same experimental treatment were pooled together and washed 
again with Leibovitz medium by centrifugation (750 X g for 10 min at 4ºC). The 
cellular recovery rate and viability were determined for each experimental 
group.
A 250-µl sample of the cellular suspension from each experimental group 
(500,000 cells, approximately) was carefully loaded on the top of a Percoll 
density gradient prepared as described previously (3). In brief, the hyperbolic 
gradient of Percoll was prepared by mixing 6 ml of a 50% Percoll solution with 3 
ml of a 15% Percoll solution at a rate of 0.25 ml/min. After centrifugation (3,000 
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X g for 25 min at 4ºC), 9 fractions (1 ml each) were collected manually,  
centrifuged (750 X g for 10 min at 4ºC), and pellets were resuspended in 200 µl 
fresh medium. The viability and recovery percentage of each fraction were 
determined for each experimental group. Cells in fraction 1 (bottom of the 
gradient) contained the HD or storage melanotrope cell subpopulation, whereas 
secretory or LD melanotropes separated in fractions 5 to 7 (3-7).
Determination of apoptosis
As indicated above, melanotrope cells were cultured in 35-mm dishes 
and exposed to 10-4 M apomorphine or 10-7 M NPY (for cultures from black-
adapted frogs), or to 10-5 M TRH (for cultures from white-adapted animals). 
After the 72-h treatment period, medium was removed and cells were fixed with 
ethanol:acetic acid (3:1) as described previously for the same cell model (7). 
Briefly, nuclei were stained with 4'-6-diamidino-2-phenylindole (DAPI) to reveal 
the nuclear condensation and the chromatin fragmentation characteristic of 
apoptosis (28) and fluorescence was visualized in a Universal microscope 
(Zeiss, Jena, Germany) with a Fluar X40 objective in the epifluorescence mode 
(Nikon Corp., Tokyo, Japan). Quantitative evaluation of apoptotic cells by DAPI 
staining was performed by counting about 200 cells randomly selected in at 
least two plates per treatment group and experiment.
Measurement of cell proliferation
The proliferation index of melanotropes was evaluated after the 72-h 
culture period in the absence or presence of the test substances as described 
previously (7). After removal of the medium, cells were exposed to 10-6 M BrdU 
for 2 h at 26ºC, rinsed with 0.01 M PBS (pH 7.2), and then fixed in the culture 
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dishes overnight with Bouin’s fixative. The BrdU-incorporating cells were 
identified immunocytochemically after sequential incubation in 5% H2O2 (30 
min, room temperature), 2 N HCl (30 min, 37ºC), 0.01% trypsin type I in PBS (5 
min, 37ºC), 1% BSA in PBS (30 min, room temperature), and an anti-BrdU 
monoclonal antiboby (overnight, 4ºC). Finally, cells were incubated with 
biotinylated goat anti-mouse IgG and avidin-biotin-peroxidase complex (1 h 
each, room temperature) and cell-bound peroxidase activity was revealed with 
DAB. The specificity of the immunoreaction was checked by omission of the 
primary antiserum. All controls were processed concurrently with melanotrope 
culture samples using identical protocols.
The immunostaining was visualized under a light microscope fitted with an 
X40 objective, and the proliferation rate was calculated on, at least, two plates 
per treatment group and experiment. In each plate, microscopic fields were 
randomly selected and, at least, 600 cells were examined.
Statistical analysis
Data are expressed as mean ± standard error of the number of 
experiments indicated in each figure. Differences in cell distribution were 
statistically analyzed by the Chi-square test. Two-way (for percentages of 
melanotrope cells) or one-way (for apoptotic and proliferation rates) analysis of 
variances (ANOVA), followed by a post hoc Duncan's test for multiple 
comparison, were applied to compare experimental treatments. Statistical 
analyses were assessed with the software Statistica for Windows (Statsoft Inc., 
Tulsa, OK). Differences were considered to be significant at P < 0.05.
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RESULTS
Recovery and viability of melanotrope cells after the experimental treatments
After dispersion of intermediate lobes from black- and white-adapted 
frogs, the cell yields were similar [47,280 ± 4,006 (n = 9 independent 
experiments) and 53,760 ± 5,133 (n = 5) cells/intermediate lobe, respectively], 
and the viability of the cells was always over 90% in both groups of animals. 
Results on the recovery of cells from the cultures by EDTA/trypsin 
treatment after treatment of melanotropes with the different test substances are 
shown in Table I. None of the treatments affected the recovery rate of cells 
from the plates except for apomorphine-treated cultures, which exhibited a 
significantly lower value than the corresponding control cultures. In contrast, 
subsequent separation of the resulting cells by density gradients did not affect 
the recovery of cells, which was similar in all the experimental groups (36.5 ± 
6.1%, 49.1 ± 9.7%, 33.2 ± 9.1%, 57.8 ± 14.5%, and 48.8 ± 20.3% for black-
background adaptation control, apomorphine-treated cells, NPY-treated cells, 
white-background adaptation control, and TRH-treated cells, respectively). 
Effects of apomorphine and NPY on cultured melanotrope cells from black-
background adapted frogs
Separation in Percoll density gradients of the total population of 
melanotrope cells from black-adapted animals after the 72-h period under 
control conditions yielded a bimodal distribution of cells through the gradient 
(Fig. 1A). Specifically, melanotropes were separated into two distinct zones of 
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the gradient, fraction 1 and fractions 5 to 7, which corresponded to the 
subpopulations of hormone-storage (HD) and secretory (LD) melanotropes, 
respectively, which have been previously characterized in detail (3-7). Cells 
separated in these fractions accounted for by 77.2% of the total number of cells 
recovered from the gradient, among which the number of secretory cells was 
approximately 6-fold higher than that of storage cells (Fig. 1B). 
Exposure of dispersed intermediate lobe cells from black background-
adapted frogs for 3 days to the dopamine receptor agonist apomorphine 
caused a significant modification of the sedimentation characteristics of the 
cells within the density gradient, which resulted in marked changes in the 
relative proportions of cells separated in each fraction (Chi-square test, P < 
0.05; Fig. 1A). As shown in Fig. 1B, apomorphine treatment reduced by almost 
20% the proportion of secretory cells with respect to control values, while it 
evoked a concomitant increase in the percentage of storage melanotropes, 
which was two-fold higher than that found under control conditions (Fig. 1B). 
Similar to that observed for apomorphine, long-term in vitro exposure of 
melanotrope cells from black-adapted frogs to NPY resulted in a shift of the cell 
population to the heavy fractions of the gradient (Chi-square test, P < 0.05; Fig. 
2A). Indeed, NPY increased by 24.3% the proportion of storage melanotropes 
and decreased by 18.5% that of secretory melanotropes when compared to the 
percentages obtained for the corresponding cell subpopulations from control 
cultures (Fig. 2B). 
We also assessed the rates of proliferation and apoptosis in cultures of 
melanotropes from black-background adapted animals exposed to medium 
alone or to the inhibitors apomorphine or NPY (Table I). This revealed that 
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neither apomorphine nor NPY modified the apoptotic rate of melanotropes in 
culture when compared to control values. Similarly, no differences were 
observed in the proliferation index between control and NPY-treated cultures, 
and although apomorphine-treated cells exhibited a lower BrdU-labeling index 
than control cells, this difference did not reach statistical significance. 
Effects of TRH on cultured melanotrope cells from white-background adapted 
frogs
The distributions of both control and TRH-treated cells obtained from 
white-background adapted animals in the density gradient are illustrated in 
figure 3A. After a 72-h culture period, melanotropes from both experimental 
groups essentially separated into the HD and LD fractions (1 and 5 to 7, 
respectively). Actually, the overall percentage of cells contained in both cell 
subsets for control and TRH-treated cultures represented 85.2% and 89.5%, 
respectively, of the total number of cells recovered from the gradient. However, 
the proportion of melanotropes separated in each density fraction was 
significantly different for each experimental group (Chi-square test, P < 0.05; 
Fig. 3A). Thus, whereas TRH increased the number of secretory cells (16.1%), 
it concurrently decreased that of storage melanotropes (11.8%) when 
compared to the corresponding values obtained from cells cultured in medium 
alone. In contrast to this effect of TRH on the balance between the two 
melanotrope cell subtypes, the tripeptide did not alter the rate of apoptosis or 
proliferation in melanotropes from white-adapted frogs in culture (Table I).
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DISCUSSION
Previous studies on skin pigmentation adaptation to background color 
have shown that the relative proportions of the two functionally distinct cell 
subsets that comprise the population of melanotrope cells of the frog 
intermediate lobe (3-5, 29) change reciprocally in strict correspondence with the 
α-MSH requirements imposed by the environment (6-7). Thus, in conditions of 
high α-MSH demand, under a black background, the highly active melanotrope 
cell subset predominates over the hormone-storage melanotrope subpopulation 
whereas similar proportions of both melanotrope cell subtypes are present in 
the intermediate lobe of animals that require low plasma α-MSH levels, i.e. 
white-background adapted animals. The results presented in these works 
suggested the existence of a functional link between the adaptation process 
and the balanced interconversions of secretory and storage melanotropes (6-7). 
In the present study, we demonstrate that the hypothalamic factors NPY, 
dopamine and TRH play a critical role in the physiological control of 
intermediate lobe function through their action on the determination and 
maintenance of the specific functional state of melanotropes.
Involvement of dopamine in the neuroendocrine regulation of skin color 
adaptation in amphibians is supported by earlier studies demonstrating that 
agents that induce catecholamine depletion in fibers reaching the intermediate 
lobe caused skin darkening (for review see Ref. 15). Accordingly, our first set of 
studies was aimed at elucidating the effects of the major cathecolaminergic 
inhibitor dopamine on melanotrope cells from animals displaying high plasma α-
MSH levels, that is, black-background adapted frogs. Thus, long-term in vitro
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treatment of intermediate lobe cells from these animals, which essentially 
correspond to secretory or LD melanotropes (6, 7), caused a significant 
modification of the sedimentation characteristics of the cells within the density 
gradient with respect to untreated controls, which resulted in marked changes 
in the relative proportions of the two cell subtypes. Specifically, apomorphine 
reduced the percentage of secretory cells and evoked a concomitant increase 
in that of storage cells. Inasmuch as these changes are reminiscent of those 
observed during adaptation of the animals in vivo to a white background (6-7), 
our results strongly suggest that an important mechanism employed by 
dopamine to regulate the adaptation process would be by inducing secretory 
melanotropes to acquire the hormone-storage phenotype. 
Since percentages of the two subtypes of melanotropes in the 
intermediate lobe are relative and depend on the total number of cells of the 
gland, we assessed the rates of proliferation and apoptosis in the cell cultures 
to ascertain whether apomorphine-induced changes resulted from true 
conversions of cells from one subpopulation (LD) into its counterpart (HD) or, 
alternatively, from an increase in proliferation of storage cells and/or a 
concomitant disappearance of secretory cells. This revealed that, in fact, the 
BrdU-labeling index in apomorphine-treated cultures was slightly, albeit not 
significantly, lower than that observed in the corresponding controls. This 
indicates that the net increase in the number of storage melanotropes induced 
by apomorphine can not be accounted for by an enhanced rate of cellular 
proliferation, and therefore that the cells that separate in this subpopulation 
after apomorphine treatment do not derive from mitosis of preexisting cells. In 
support of these findings, it has been shown that dopamine or its agonists 
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inhibit proliferation of rat melanotropes both in vivo and in vitro (30-32), as well 
as that of other pituitary cell types such as lactotropes (33, 34). Actually, 
dopamine and its agonists are commonly used in prolactinoma therapy to 
reduce tumor size because of their well-known antiproliferative (35) and 
cytotoxic (36) properties and we consequently expected apomorphine to 
increase apoptosis in our cultures. However, the apoptotic rate was similar in 
control and apomorphine-treated cultures. Nevertheless, at this point we should 
introduce the caveat that assessment of apoptosis might have been slightly 
underestimated if cells that progressed into later stages of apoptosis detached 
from the culture dish and were thus undetectable, as suggested by the lower 
cell recovery found in apomorphine-treated cultures. This caution 
notwithstanding, it must be emphasized that even a selective disappearance of 
secretory melanotropes caused by apomorphine could not account for the 
changes observed. Therefore, when viewed as a whole, our results strongly 
suggest that storage melanotropes appear as a result of the apomorphine-
induced conversion of secretory cells.
We also tested the effect of long-term in vitro exposure of melanotrope 
cells from black-adapted frogs to the naturally occurring hypothalamic inhibitor 
NPY (27). Results from these experiments showed that NPY caused a marked 
decrease in the number of secretory cells and a concurrent increase in that of 
storage cells, without altering the rate of either cellular proliferation or 
apoptosis. These findings indicate that, as found for apomorphine, NPY is able 
to induce the transition of melanotrope cells from a highly active secretory 
physiological condition to a storage state. Interestingly, the relative proportions 
of the two subtypes of melanotropes after culture of intermediate lobe cells 
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from black-adapted frogs in the presence of either apomorphine or NPY were 
strikingly similar to those observed in intermediate lobes of white-background 
adapted frogs (6-7). These results support the idea that these inhibitors are 
able to induce in vitro the same cellular changes that occur in vivo during white-
background adaptation. Moreover, they strongly suggest that dopamine and 
NPY play a pivotal role during this physiological process. Consistent with this 
notion, quantitative immunocytochemistry and in situ hybridization studies of  
the hypothalamus from black-background adapted Xenopus have shown that 
the levels of NPY mRNA and NPY-immunoreactivity are very low in the 
ventrolateral part of the suprachiasmatic nucleus, where NPY-producing 
neurons controlling intermediate lobe function are located (37-39). In contrast, 
high mRNA levels and NPY-immunoreactivity are found in this hypothalamic 
region in white-adapted toads (38, 39).
Having established that hypothalamic inhibitors can mimic in vitro the 
cellular changes that occur during white-background adaptation, we next asked 
whether TRH, the major hypothalamic stimulator for amphibian melanotrope 
cells (15, 24-26), could induce the cellular changes observed during adaptation 
of frogs to a black background [i.e. conversion of storage cells into secretory 
cells (6-7)]. Indeed, in the melanotrope population of white-adapted frogs, 
which comprises similar proportions of both cell subtypes (6-7), long-term in 
vitro exposure to TRH markedly increased the number of secretory 
melanotropes while it concurrently decreased that of hormone-storage cells. 
Inasmuch as TRH did not alter apoptosis or proliferation in these cultures, such 
changes in proportions are, necessarily the result of the conversion of storage 
cells into active melanotropes. Moreover, the percentages of both types of 
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melanotropes observed after treatment of intermediate lobe cells from white-
adapted animals with TRH were virtually identical to those found in animals 
physiologically adapted to a black background (6-7). Therefore, our results 
demonstrate that TRH can mimic in vitro the effects caused by black-
background adaptation on frog melanotrope cell subpopulations, and thereby 
strongly support the involvement of the tripeptide in the adaptation process.
The concept that the hypothalamus can control the composition of the 
population of a given pituitary cell type, i.e. the balance between its distinct 
subpopulations, raises two important questions. The first relates to the possible 
physiological relevance of such regulatory mechanism. The present results, 
together with those reported previously on amphibian melanotropes may 
provide a good example in that regard. As previously demonstrated (3-5, 29), 
frog storage melanotropes are heavily granulated and contain high intracellular 
α-MSH levels, although they show low levels of hormone biosynthesis and 
release under basal culture conditions. More importantly, storage melanotropes 
also exhibit a limited response, in terms of both POMC expression and α-MSH 
release, to in vitro short-term treatment with TRH (3-4). In addition, among the 
three major secretoinhibitors of the frog intermediate lobe (23), dopamine, 
GABA and NPY, only high concentrations of the latter are able to reduce the 
already low secretory activity of hormone-storage melanotropes (5, 29). In clear 
contrast, secretory melanotropes in culture are highly responsive in the short-
term to TRH stimulation (4), as well as to the hypothalamic inhibitors dopamine, 
GABA, and NPY (5, 29). In view of these and our present findings, it seems 
reasonable to suggest that the hypothalamus controls plasma α-MSH levels 
during the process of adaptation to background color by regulating the total 
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activity of the intermediate lobe through two different, but interrelated 
mechanisms: 1) in the short term, by acutely controlling hormone synthesis and 
release, and 2) in the long term, by converting highly secretory cells into 
hormone-storage cells and vice versa. This process is graphically illustrated in 
Fig. 4. Thus, during white-background adaptation, dopamine and NPY would 
reduce α-MSH levels in the short term by inhibiting its release from the highly 
responsive, predominant secretory or LD subtype in black-adapted frogs. At the 
same time, dopamine and NPY would enable a more effective long-term 
reduction of α-MSH production by causing a lasting conversion of highly active 
and responsive secretory melanotropes into poorly responsive hormone-
storage cells. Conversely, during adaptation from a white to a black 
background, the required high α-MSH levels would be achieved primarily by 
TRH in the short term through stimulation of α-MSH release from highly 
responsive melanotropes. Concurrently, TRH would also induce a long-term 
conversion of the hormone-storage cells into their active counterparts. In sum, 
this system would provide the hypothalamus an additional, long-lasting 
mechanism to finely regulate the activity of the intermediate lobe in an effective 
and economical manner. 
The second question that derives from our findings is two-pronged: what 
form does the conversion of cells from one subpopulation into the other cell 
subtype take, and what precise factors and events do underlie this regulatory 
process? Regarding the first part of the question, we and others have 
previously suggested that heterogeneity within pituitary cell types, such as 
melanotropes (7), somatotropes (10), gonadotropes (8,9) and lactotropes (40), 
is in fact the reflection of cells undergoing a secretory cycle. This cellular 
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process would comprise the transition of cells from a phase or subpopulation to 
the other one due not only to a loss or increase in granule content, but also to 
changes in key functional features of the cells. In the case of melanotropes, 
such changes would include selective responsiveness to regulatory factors, as 
well as the differential regulation of the synthesis, maturation, acetylation rate, 
and secretion of α-MSH along with variations in other important components of 
the secretory pathway (41, 42). Regarding the second part of the question, the 
precise regulatory mechanisms that underlie the melanotrope cell secretory 
cycle await elucidation. One can envision a number of points at which the 
activity and responsiveness of melanotrope cells can be regulated. This might 
include from transcription factors to signaling enzymes and proteins, as well as 
membrane receptors. To give just an example, bromocriptine has been shown 
to regulate the type of G proteins (43) and dopamine receptor isoforms (44) 
expressed in rat melanotrope cells. Future studies should aim at ascertaining 
the points at which this regulation is primarily exerted, and at determining 
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Figure Legends
FIG 1: (A) Distribution through the Percoll density gradient of melanotrope cells 
from black-background adapted frogs cultured in medium alone (solid bars) or 
in the presence of 10-4 M apomorphine (open bars) for 3 days. Data are 
expressed as mean ± SE of 5 independent experiments. Statistical differences 
were assesed by Chi-square test, P < 0.05 vs. control cultures. (B) Percentage 
of cells recovered in the low density fractions of the gradient (LD, fractions 5-7), 
corresponding to secretory melanotropes, and in the high density fraction (HD, 
fraction 1), corresponding to hormone-storage melanotropes, from the 
intermediate lobe of black-background adapted frogs cultured for 3 days in the 
absence (solid bars) or in the presence of 10-4 M apomorphine (open bars). 
The data represent the mean ± SE of 5 independent experiments. Statistical 
differences were assessed by two-way ANOVA followed by the Multiple 
Comparison Duncan’s test. *; P < 0.05 vs. control cultures.
FIG 2: (A) Distribution through the Percoll density gradient of melanotrope cells 
from black-background adapted frogs cultured in medium alone (solid bars) or 
in the presence of 10-7 M NPY (open bars) for 3 days. Data are expressed as 
mean ± SE of 5 independent experiments. Statistical differences were assesed 
by Chi-square test, P < 0.05 vs. control cultures. (B) Percentage of cells 
recovered in fractions 5-7 of the gradient (low density –LD- or secretory 
melanotropes), and in fraction 1 (high density –HD- or hormone-storage 
melanotropes), from the intermediate lobe of black-background adapted frogs 
cultured for 3 days in the absence (solid bars) or in the presence of 10-7 M NPY 
(open bars). The data represent the mean ± SE of 5 independent experiments. 
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Statistical differences were assessed by two-way ANOVA followed by the 
Multiple Comparison Duncan’s test. *; P < 0.05 vs. control cultures.
FIG 3: (A) Distribution through the Percoll density gradient of melanotrope cells 
from white-background adapted frogs cultured in medium alone (solid bars) or 
in the presence of 10-5 M TRH (open bars) for 3 days. Data are expressed as 
mean ± SE of 3 independent experiments. Statistical differences were assesed 
by Chi-square test, P < 0.05 vs. control cultures. (B) Percentage of cells 
recovered in fraction 1 and fractions 5-7, corresponding to hormone-storage 
(HD cells) and secretory melanotropes (LD cells), respectively, from the 
intermediate lobe of white-background adapted frogs cultured for 3 days in the 
absence (solid bars) or in the presence of 10-5 M TRH (open bars). The data 
represent the mean ± SE of 3 independent experiments. Statistical differences 
were assessed by two-way ANOVA followed by the Multiple Comparison 
Duncan’s test. *; P < 0.05 vs. control cultures.
FIG 4: Representation of the secretory cycle exhibited by frog melanotrope 
cells. Black-background adaptation (black arrow) would induce the conversion 
of hormone-storage melanotropes into highly active secretory melanotropes via
an increase in stimulatory hypothalamic inputs (i.e. enhanced TRH secretion 
and, likely, blockade of inhibitory inputs), in order to increase hormone 
production. Conversely, during white adaptation (open arrow), in which a lower 
amount of hormone is required, an inverse process would occur, mediated by 
an increase in inhibitory hypothalamic inputs (i.e. increased dopamine and NPY 
release). Small vesicles represent the secretory granule content; undulating 
lines indicate the amount of the α-MSH precursor transcripts; and gray arrows 
represent the secretory activity of α-MSH.
Table I: Apoptotic and proliferation rates in cultures of intermediate lobe cells 
from black- and white-adapted frogs after a 3-day culture period in the absence 
(control) or the presence of various test substances.







Cell recovery after 
culture (%)
51.6 ± 7.4 28.8 ± 5.2* 44.3 ± 9.7 56.0 ± 6.8 51.8 ± 9.7
Apoptotic index 
(%)
2.55 ± 0.71 1.30 ± 0.19 2.85 ± 1.52 2.56 ± 1.00 1.55 ± 0.36
Proliferation rate 
(%)
0.87 ± 0.32 0.10 ± 0.14 0.80 ± 0.25 0.73 ± 0.59 0.60 ± 0.12
Data are expressed as percentages and represent the mean ± SE of 3 
independent experiments. Statistical differences were analyzed by one-way 
ANOVA followed by the Multiple Comparison Duncan’s test. *; P < 0.05 vs.
corresponding control.
Fig. 1
Fig. 2
Fig. 3
Fig. 4
